, , , ,
doi.org/10.1007/s002590050064, hdl.handle.net/1765/64878
European Journal of Nuclear Medicine
Department of Internal Medicine

de Jong, M., Bakker, W., Krenning, E., Breeman, W., van der Pluijm, M., Bernard, B., … Mäcke, H. (1997). Yttrium-90 and indium-111 labelling, receptor binding and biodistribution of [DOTA0,D-Phe1,Tyr3]octreotide, a promising somatostatin analogue for radionuclide therapy. European Journal of Nuclear Medicine, 24(4), 368–371. doi:10.1007/s002590050064